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Iloprost (IP) stimulation (1 AM, 2 h) of Flag-epitope-tagged human IP prostanoid receptor (FhIPR) expressed in HEK293 cells resulted in
specific decrease of endogenous Gsa protein in detergent-insensitive, caveolin-enriched, membrane domains (DIMs). Receptor protein
FhIPR, caveolin, Gia and GPI-linked, domain markers CD55 and CD59 were unchanged. The same result was obtained in HEK293 cells
expressing FhIPR-Gsa fusion protein. The endogenous Gsa decreased, but the level of Flag-hIPR-Gsa protein did not change. The specific
depletion of domain-bound pool of Gsa as consequence of iloprost stimulation was also demonstrated in membrane domains prepared
according to alkaline treatment plus sonication protocol (detergent-free procedure of Song et al. [J. Biol. Chem. 271 (1996) 9690]). Our data
further indicated that in control, quiescent cells only a very small amount of IP prostanoid receptor was present in DIMs together with large
amount of its cognate Gsa protein. Expressed in quantitative terms, DIMs contained 30–40% of the total cellular amount of G proteins
whereas the content of IP prostanoid receptors was 1–3%. The dominant portion (>95%) of FhIPR as well as FhIPR-Gsa was localised in
high-density area of the gradient containing detergent-solubilised proteins. FhIPR and FhIPR-Gsa distribution was similar to that of
transmembrane plasma membrane (PM) markers (CD147, MHCI, CD29, Tapa1, the a subunit of Na,K-ATPase, transmembrane form of
CD58 and CD44). All these proteins are known to be fully solubilised by detergent and thus unable to float in density gradient.
Our data indicate that (i) long-term agonist stimulation of IP prostanoid receptor is associated with preferential decrease of its cognate G
protein Gsa from membrane domains; receptor level is unchanged. (ii) Very small fraction (1–3%) of total cellular amount of receptors is
recovered in DIMs together with roughly 40% of G proteins. These data suggest a ‘‘supra-stoichiometric’’ arrangement of G proteins and
corresponding receptors in DIMs.
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Abbreviations: BPB, bromphenol blue; DIMs, detergent-insoluble or detergent-insensitive membrane domains; DMEM, Dulbecco’s modified Eagle’s
medium; FLAG, Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys; FhIPR, Flag-tagged form of human IP prostanoid receptor; FhIPR-Gsa, FhIPR-Gsa fusion protein; G
proteins, heterotrimeric guanine nucleotide-binding regulatory proteins; Gsa, G protein stimulating adenylyl cyclase activity; Gia, G proteins inhibiting
adenylyl cyclase activity in pertussis-toxin sensitive manner; Gqa/G11a, G proteins stimulating phosholipase C in pertussis-toxin independent manner; GPCR,
G protein coupled receptor; HEK, human embryonic kidney; GPI, glycosylphosphatidylinositol;Mr, relative molecular weight; PBS, phosphate-buffered saline;
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receptors (GPCRs) results in internalisation [1–4] and spe-
cific down-regulation of the cognate trimeric G proteins (for
review see [5,6]. Internalised G proteins may be recovered in
low-density or light vesicular membranes (endosomes) dis-
tinct from bulk of plasma membranes (PM) [7–12]. Fast
agonist-induced internalisation of Gsa was recently demon-
strated by Yu and Rasenick [13]. Hormone-induced changes
in cellular localisation of G proteins have been comprehen-
sively reviewed by Svoboda and Novotny [6].
At least in some signalling cascades, G protein internal-
isation exhibits different characteristics when compared
with internalisation of the corresponding receptors. TRH
receptor (TRH-R) is internalised within minutes via clathrin-
dependent pathway [3,14–17], whereas Gqa/G11a internal-
isation does not begin earlier than after 1 h and is fully
manifested after several hours of agonist stimulation [2,3].
Similar difference exists for Gqa/G11a and muscarinic
acetylcholine receptors [18]. Thus, G protein internalisation
might proceed as caveolae-mediated endocytosis, which has
been described as a rather slow endocytotic pathway [19].
This possibility has been supported by our previous data
showing depletion of Gqa/G11a proteins in DIMs/caveolar
pool after long-term TRH stimulation [20].
In the present work, we have studied the Gsa-mediated
cascade initiated by IP prostanoid receptors. HEK293 cells
expressing the Flag-epitope-tagged form of human IP pros-
tanoid receptor (FhIPR) [21] or FhIPR-Gsa fusion protein
[22] were used as new methodological tools to compare the
hormone-induced changes of both the receptor and its cog-
nate G protein simultaneously in distinct regions of the cell
membrane. These regions (domains) were distinguished by
nonionic detergent solubility or extraction in a highly alkaline
solution of 0.5 M Na2CO3 (pH 11) plus sonication. Distri-
bution of IP prostanoid receptors and Gsa protein between
detergent-insoluble (DIMs) and detergent-solubilised phase
was compared with distribution of a number of membrane
markers representing the integral (transmembrane) as well as
GPI-domain-bound proteins. Hormone-induced changes in
composition of DIMs were compared with those in detergent-
free preparations of membrane domains prepared by alkaline
treatment of cell homogenates in 0.5 M Na2C03, pH 11
[23,24]. In order to complement the previous studies estimat-
ing the G protein/GPCR stoichiometry in the whole cell or
crude membrane preparations only [5,25–28], here we have
also analysed the quantitative proportion between IP prosta-
noid receptor and Gsa in membrane domains.
2. Materials and methods
2.1. Chemicals
Tissue culture reagents and media were supplied by
Gibco or Sigma. All other chemicals and drugs, includingCaveolin-oriented antisera C13630 and C37120 were pur-
chased from Transduction Laboratories (Nottingham, UK),
antibodies against Gsa (G-5040), VSV (V-5507) and Flag
(M5, IB13091) were from Sigma. Anti-VSV-G monoclonal
antibody (cat. no. 1667351) and Complete protease inhibitor
cocktail (cat. no. 1697498) were from Roche Applied
Sciences (Mannheim, Germany).
2.1.1. Construction of Flag-epitope tagged version of
human IP-prostanoid receptor (FhIPR)
An hIPR cDNAwas obtained from Dr. Mark Abramovitz
(Department of Biochemistry and Molecular Biology, Merck
Frost Centre for Therapeutic Research, Quebec, Canada). To
incorporate the Flag epitope (Asp-Tyr-Lys-Asp-Asp-Asp-
Asp-Lys) at the amino acid terminus of cDNA, a set of
PCR oligonucleotide primers was used. The sense oligonu-
cleotide was 5V-AAGGATCC GCACCCATGðG ACTA-
CAAGGACGACGATGATAA G)GCGGATTCGTGCAG-
GAACC-3V; the underlined bases refer to restriction sites of
BamHI and NcoI, respectively, with Flag epitope bases in
parentheses. The antisense oligonucleotide was 5V-
AAGAATTCTCAGCTTGAAATG(TCA)GCAGAG-3V; the
underlined bases refer to EcoRI restriction site, with stop
codon in parentheses. The PCR amplified fragment was
digested with BamHI and NcoI and ligated into pcDNA3
(InVitrogen, San Diego, CA) through these restriction sites.
Introduction of the NcoI site at the start codon allowed the
selection of positive clones onNcoI digestion and agarose gel
electrophoresis. The cDNA construct was fully sequenced.
2.1.2. Construction of FHIPR-Gsa fusion protein
Using FhIPR cDNA, PCR amplification was used to
remove the stop codon. At the same time, the last amino
acid, cysteine, was changed to glutamic acid due to incorpo-
ration of anXhoI restriction site to allow fusion of Gsa cDNA.
This fragment of FhIPR was cloned into the EcoRI/XhoI site
of pcDNA3. Rat HA-Gsa(L) cDNA (haem-agglutinin-epi-
tope tagged from of the rat long variants of Gsa) was obtained
from Dr. M.J. Levis and Dr. H.R.Bourne, UCSF, CA, USA).
To enable fusion with the FhIPR cDNA, bases 5V to the
operon reading framewere changed using PCR to generate an
XhoI restriction site, while an XbaI site was incorporated after
the stop codon. The sense oligonucleotide used was: 5V-
CCGCTCGAG ATGGGCTGCCTCGGCAACAG-3V; the
underlined bases refer to the XhoI digestion site. The anti-
sense oligonucleotide used was: 5V-TGCTCTAGATTAGAG-
CAGCTCGTATTGGC-3V; the underlined based refer to the
XbaI site. The PCR-amplified fragment was digested with
XhoI and XbaI and ligated to the FhIPR in pcDNA3 at XhoI/
XbaI sites.
2.2. Cell culture and stable expression
HEK293 cells were seeded into 100-mm culture dishes
and grown to 60–80% confluency (18–24 h) before trans-
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DOTAP reagent {N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-tri-
methylammonium metylsulfate} (Boehringer Mannheim).
Cells stably expressing a G418 sulfate (Calbiochem) resis-
tance marker were picked and transferred into 24-well
plates. About 40 clones of each cDNA were amplified.
HEK293 cells expressing FLAG-tagged form of human IP
prostanoid receptor (clone FhIPR) or FhIPR-Gsa fusion
protein (clone FhIPR-Gsa) were cultivated in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% (v/v)
newborn calf serum according to Fong et al. [21] and Fong
and Milligan [22]. Geneticin (800 Ag) or hygromycin (200
Ag) were included in the course of cell cultivation. The cells
were grown to 60–80% confluency before harvesting and
beginning of experiments.
2.3. Isolation of detergent-resistant membrane domains
2.3.1. Protocol A
HEK293 cells expressing Flag-hIPR or Flag-hIPR-Gsa
were untreated (control) or treated with hormonal agonist (1
AM iloprost, 2 h) and then harvested. The cells from nine
flasks (80 cm2 each) were collected by low-speed centrifu-Fig. 1. Iloprost-stimulation of Flag-hIPR induces preferential decrease of the co
expressing Flag-epitope tagged version of human prostanoid receptor (FhIPR) were
for 2 h. Iloprost stimulation was discontinued by aspiration of incubation media an
flasks by centrifugation for 10 min at 1800 rpm. Cell sediment was washed once
samples and extracted with 1% (v/v) TX-100 for 45 min on ice. The TX-100 extra
in Section 2. Constant volume of 0.3 ml of DIMs (4–6) or detergent-solubilised (9
PAGE and immunoblotting with specific antibodies. The data represent the typical
Parallel samples of density gradient fractions analysed for Gsa content were subje
Gi2a. St, 20 Ag of rat brain cortex microsomes.gation at 1800 rpm for 10 min (0–4 jC), washed once in
PBS and resuspended on ice by repeated pipetting in 1 ml of
TME buffer (20 mM Tris–HCl, pH 7.5, 3 mM MgCl2, 1
mM EDTA and 150 mM NaCl). Cell suspension was diluted
to the same protein concentration in control and agonist-
stimulated samples and fresh PMSF (200 mM stock in
isopropylalkohol) plus complete protease inhibitors cocktail
in TME buffer was added to 1 mM final concentration of
PMSF. Subsequently, 1 ml of 2% (v/v) Triton X-100 in
TME was added and mixed with the cell suspension by
repeated pipetting. After 45 min on ice (box with ice in cold
room equilibrated to 0–4 jC), 2 ml of 1% TX-100 cell
extract was mixed with 2 ml of ice-cold 80% w/v sucrose,
transferred into a centrifuge tube of Beckman SW 41 rotor
and overlaid with 35% (4 ml) and 5% (4 ml) w/v sucrose.
This simple ‘‘5/35/40’’ type of gradient was routinely used
in majority of other studies for membrane domain isolation
[29–33]. Great care was devoted to prevent mixing of the
lower with higher sucrose layers in the course of preparation
of the density gradient. Density gradient fractions 1–12 (1
ml each) were collected manually from the meniscus after
centrifugation for 24 h at 39000 rpm (188000 g), frozen
in liquid nitrogen and stored at  80 jC until use.gnate Gsa protein in DIMs. Gia protein is unchanged. (A) HEK293 cells
grown to 60–80% confluency and incubated without or with 1 AM iloprost
d harvesting the cells from nine (control) and nine (iloprost-treated) 80-cm2
, diluted to the same protein concentration in control and iloprost-stimulated
ct was fractionated on 40/35/5% (w/v) sucrose density gradient as described
–11) fractions was TCA precipitated and analysed for Gsa content by SDS-
fractionation procedure. St, 20 Ag of guinea pig myocardial membranes. (B)
cted to immunodetection of Gi proteins by SG antiserum specific for Gi1a/
et Biophysica Acta 1691 (2004) 51–652.3.2. Protocol B
When indicated, cells expressing FhIPR and FhIPR-Gsa
were also fractionated on a more complicated 5/10/15/20/
25/30/35/40% (w/v) sucrose gradient. Two ml of cell extract
in 1% v/v TX-100 were mixed with 2 ml of 80% (w/v)
sucrose and overlaid subsequently with 35, 30, 25, 20, 15,
10% (1 ml each) and 5% (w/v) sucrose (1.5 ml). Density
gradient fractions 1 (0.5 ml, 5% sucrose), 2 (1 ml, 5%
sucrose), 3 (1 ml, 10% sucrose), 4 (1 ml, 15% sucrose), 5 (1
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transmembrane (MHCI and CD147) PM markers was compared in control and i
gradient. The behaviour of the immuno-protein molecules when extracted in 1% (v
intensively studied in human and mouse lymphocytes [42–47]. In close analogy w
density area of gradient containing 15–20% sucrose, while the transmembrane pro
area of gradient containing the 40% sucrose. The immunoblots show typical gradml, 20% sucrose), 6 (1 ml, 25% sucrose), 7 (1 ml, 30%
sucrose), 8 (1 ml, 35% sucrose) and 9–12 (1 ml, 40%
sucrose) were collected from the meniscus, frozen in liquid
nitrogen and stored at  80 jC.
2.4. Isolation of membrane domains by alkaline treatment
Cells (F agonist) were harvested from 9 flasks (80 cm2
each), collected by low-speed centrifugation (1800 rpm, 10ensity gradient profile of domain-bound (caveolin, CD55 and CD59) and
loprost-treated FhIPR-expressing cells fractionated on a ‘‘5/35/40’’ type of
/v) TX-100 and fractionated on flotation sucrose density gradients has been
ith lymphocytes, GPI-bound proteins CD55 and CD59 floated up to the low-
teins MHCI and CD147 were fully solubilised and remained in high-density
ient profiles selected from eight independent fractionation procedures.
Fig. 3. Statistical analysis of Gsa, Gia and caveolin content in DIMs
isolated from Flag-hIPR expressing cells. DIMs (low-density fractions 4–
6) and detergent-solubilised, high-density fractions 9–12 were prepared on
a ‘‘5/35/40’’ type of gradient by three independent fractionation procedures
from control and iloprost-treated FhIPR cells, analysed for respective
signalling molecules and the immunoblot signals were assessed by
densitometric scanning. Data obtained in control and agonist-stimulated
samples were expressed as percent of total signal recovered in all fractions,
averaged and expressed as meanF S.E.
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protein concentration in control and agonist-stimulated
samples and suspended on ice in 1 ml of TME buffer
containing fresh 1 mM PMSF plus protease inhibitors
mixture. The resulting cell suspension was transferred to a
5-ml Teflon-glass homogeniser (Brown) and diluted 1:1
with ice-cold 1 M Na2CO3, pH 11. After brief homogeni-
sation (1 min, 1700 rpm), the sample was transferred to a
centrifugation tube of Beckman SW 41 rotor and sonicated
at low-energy output for minimum time to achieve degra-
dation of the gel-like material formed by sodium bicarbon-
ate addition. When using Cole-Parmer ultrasound generator
(4710 Series, Chicago), this was achieved by tuning the
output conditions to a very tiny sound (decreasing energy
from force 5 to force 2) and sonication in ice-water slurry
for 3 10 s. These carefully controlled conditions of
ultrasound exposure were used because drastic sonication
(i.e., force 5 from Cole-Parmer ultrasound generator) is
evidently associated with degradation of functional coupling
between GPCRs and cognate G proteins [34]. Afterwards, 2
ml of completely fluid ‘‘alkaline-treated‘‘ cell homogenate
was mixed with 2 ml of ice-cold 80% (w/v) sucrose,
overlaid with 35%, 30%, 25%, 20%, 15%, 10% (1 ml each)
and 5% (1.5 ml) sucrose and centrifuged for 24 h at 39 000
rpm (188000 g). Density gradient fractions 1–12 were
collected from top to bottom, frozen in liquid nitrogen and
stored at  80 jC.
2.5. Production of antisera
G protein-specific antibodies were raised in rabbits
obtained from VELAZ, Prague (SG and CQ) or in New
Zealand White rabbits, Glasgow (CS). Immunisation was
performed with a glutaraldehyde conjugate of keyhole
limpet hemocyanin and synthetic peptide specific for a
given type of G protein. Antiserum CS was raised against
a peptide corresponding to the C-terminal decapeptide of
Gsa, RMHLRQYELL (Gsa, amino acids 385–394). Anti-
serum SG was raised against a peptide corresponding to the
C-terminal decapeptide of transducin, KENLKDCGLF
(Gta, amino acids 341–350). Antiserum CQ was produced
against peptide QLNLKEYNLV representing the C-terminal
decapeptide, which is conserved between Gqa and G11a.
This antiserum identifies both these polypeptides equally.
2.6. Immunoblotting of density gradient fractions
Sucrose density gradient fractions (constant volume of
0.75 ml) were precipitated with trichloroacetic acid (0.25
ml, 6% w/v, 1 h on ice), resuspended in 30 Al of 1 M Tris-
base and solubilised by addition of 10 Al of 4 concen-
trated Laemmli buffer without urea (0.25 M Tris–HCl, pH
6.8, 8% SDS, 40% glycerol, 0.4 M DTT, 0.04% BTB) and
heated for 3 min at 95 jC. Standard SDS-PAGE in 10% w/v
acrylamide/0.26% w/v bis-acrylamide or 12.5% w/v acryl-
amide/0.0625% w/v bis-acrylamide gels was carried out asdescribed before in detail [9]. Molecular mass determina-
tions were based on prestained molecular mass markers
(Sigma, SDS 7B). After SDS-PAGE, proteins were trans-
ferred to nitrocellulose and blocked for 1 h in 4% (w/v) BSA
in TBS (10 mM Tris–HCl, pH 8.0, 150 mM NaCl). The G-
protein-oriented antisera were added in 1% (w/v) BSA in
TBS containing 0.2% (v/v) Tween 20 and incubated for at
least 2 h. The primary antibody was then removed and the
membrane washed extensively in TBS with 0.2% (v/v)
Tween 20. The immunoblot signals were detected by ECL
technique using Super Signal West Pico or Dura (Pierce) as
substrate according to protocols originally established by
Nesbitt and Horton [35]. The developed blots were scanned
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enable quantification of the immunoblots.
2.7. Immunodetection of PM marker molecules
PM proteins CD29 (integrin h1 subunit) [36], CD44
(lymphocyte homing receptor-fagocytic glycoprotein) [37],
MHCI (major histocompatibility complex, class I), trans-
membrane form of CD58 (formerly called LFA-3) [38]
and glycosylated and non-glycosylated forms of CD147
(M6) [39] were measured as markers of transmembrane,
integral membrane proteins. CD55 (complement decay
accelerating factor) [40], GPI-bound form of CD58
(LFA-3) [38] and CD59 (complement protectin) were
measured as markers of GPI-bound, peripheral proteins
(for comprihensive information, see Ref. [41]). Character-
istic behaviour of these proteins in the course of detergent
extraction and separation on equilibrium sucrose density
gradients has been established in a number of previous
studies performed in T lymphocytes and monocytes [42–
47]. All CD membrane markers were detected by immu-
noblotting with monoclonal antibodies obtained as a kind
gift from the collection of V. Horˇejsˇı´ (Institute of Molec-
ular Genetics, Prague, CZ); the immunoblot signals were
detected by ECL technique according to Nesbitt and
Horton [35]. As classical marker of integral membrane
proteins, sodium plus potassium activated, magnesium
dependent adenosine triphosphatase (EC 3.6.1.3) (Na,K-
ATPase) was detected by antibodies purified by protein A-
affinity chromatography from rabbit polyclonal antiserum,
which was prepared against the isolated a1-subunit of this
enzyme (kind gift of Prof. Roberto Antolovic, Giessen
University, Germany).Fig. 4. Iloprost stimulation does not change the dominant pool of Flag-hIPR recepto
exposed to 1 AM iloprost for 2 h, extracted with 1% (v/v) TX-100 and fractiona
immunoblotting with Flag-oriented antibodies after resolution by standard SDS-PA
were prepared from 0.75-ml aliquots of gradient fractions. The immunoblot signal
ECL for 30 s using Super Signal West Pico (Pierce) as substrate. The typical immu
was shown.2.8. Protein determination
The method of Lowry was used for determination of
protein concentration in cell homogenates and other mem-
brane preparations from HEK293 cells. Aliquots of fractions
1–2 (100 Al), 3–6 (50 Al) and 7–12 (25 Al) were collected
from the sucrose density gradient and diluted with water to
final volume of 200 Al. Blank values were obtained from the
same type of gradient centrifuged under identical conditions
without any protein. The protein solutions were mixed with
0.3 ml of 0.1 N NaOH plus 2% Na2CO3, and after 10 min at
room temperature, 50 Al of Folin reagent (diluted 1:1 with
water) was added and mixed immediately. After 30 min of
incubation, absorbance at 720 nm was determined. Calibra-
tion curve was measured in parallel with 0, 10, 20, 30, 40,
50, 75, 100, 150 and 200 Ag of protein standard (Fraction V
bovine serum albumin, Sigma). Data were calculated by
fitting the calibration curve as quadratic equation.
physica Acta 1691 (2004) 51–653. Results
3.1. Long-term agonist stimulation is associated with
unchanged level of hIP prostanoid receptor and dramatic
reduction of Gsa protein in DIMs
Iloprost stimulation resulted in dramatic decrease of Gsa
in detergent-insensitive membrane domains (DIMs) collect-
ed in low-density area of sucrose gradient (15–25% w/v
sucrose; fractions 4–6) (Figs. 1A and 3). The content of
domain-bound Gsa in iloprost-treated samples was three
times lower than that in DIMs isolated from the same
amount of untreated cells; when expressed as percent ofr protein in detergent-solubilised fractions. Flag-hIPR-expressing cells were
ted as described in legend to Fig. 1. The receptor protein was detected by
GE. Urea-free SLB was used for solubilisation of TCA precipitates, which
s of control and iloprost-treated samples were developed simultaneously by
noblot (repeated three times) obtained from a single fractionation procedure
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decreased from 43F 3% in controls to 13F 3%. The
decrease of domain-bound pool of Gsa was specific with
respect to the interaction with activated hIP prostanoid
receptors because the level of the ‘‘non-cognate‘‘ G proteins
Gia1/Gia2 was unchanged (Figs. 1B and 3). The levels of
membrane domain markers caveolin, CD55 and CD59 (Fig.
2, upper panel) were not affected by hormonal treatment.
The same was truth for transmembrane PM markers MHCI
and CD147 (Fig. 2, lower panels), which were recovered in
high-density area of the gradient. These results indicate that
prolonged agonist stimulation did not change (in a nonspe-
cific way) the general features of the PM structure which,
when altered, could result in a changed sensitivity towards
detergent extraction. Lower levels of Gsa after hormonalFig. 5. Iloprost-stimulation does not change Flag-hIPR in both membrane domain
screened for Flag-hIPR protein in the same way as described in legend to Fig. 5, ex
signals. Under these conditions the receptor content in low-density fractions could
(8–11) density area were analysed by densitometric scanning and compared in co
fractionation procedures. (A) ECL signal developed for 30 s; (B) ECL signal devtreatment were also observed in high-density area of the
gradient (fractions 9–12) containing non-floating, deter-
gent-solubilised cell constituents (Fig. 3). This reduction,
however, was much smaller than that observed in DIMs
(fractions 4–6); it was a consequence of down-regulation of
total cellular amount of Gsa in these cells [21,22]. The ratio
between domain-bound and detergent-soluble pool of Gsa
decreased from 0.77 in control to 0.38 in iloprost-treated
samples. The total gradient content of Gsa was decreased
(down-regulated) to 48% of control values (100%).
These observations indicate that prolonged agonist-stim-
ulation of IP prostanoid receptor results in preferential
decrease of the cognate Gsa protein in DIMs. This was
demonstrated both in terms of receptor specificity and
detergent solubility. Other G proteins and PM markers wereand detergent-solubilised fractions. Density gradient fractions 1–12 were
cept that Super Signal West Dura (Pierce) was used for development of ECL
be clearly distinguished. The immunoblot signals in low- (4–6) and high-
ntrol and agonist-stimulated cells. The results represent an average of three
eloped for 5 min; (C) statistical analysis of three fractionation procedures.
Fig. 6. Simultaneous detection of Flag-hIPR-Gsa fusion protein and Gsa on the same immunoblot by Gsa-specific antibody. Distribution of both Flag-hIPR-
Gsa fusion protein and endogenous Gsa was analysed simultaneously on the same immunoblot by Gsa-specific antiserum (CS). The results are representative
of a single fractionation procedure performed on a ‘‘5/35/40’’ type of gradient.
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ceeded in parallel with down-regulation of the total cellular
amount of this G protein.
Parallel samples of density gradient fractions isolated
from iloprost-treated or untreated cells (used in previous
Gsa protein analysis) were subjected to immunodetection of
IP prostanoid receptor, Flag-hIPR. The dominant pool of
receptor protein identified by Flag-oriented antiserum was
represented by a diffuse signal spreading over a wide range
of Mr. This diffuse signal was localised in high-density area,
i.e. among detergent-solubilised cell constituents, and wasFig. 7. Depletion of endogenous Gsa and unchanged level of Gia in DIMs isolated
a ‘‘5/10/15/20/25/30/40’’ type of gradient as described in Section 2. (A) Gsa-imm
isolated from cells untreated or treated (1 AM, 2 h) with iloprost were compared on
(4–6) and soluble (9–11) fractions. Fractions analysed for Gsa were further used
from three independent fractionation procedures.unchanged by hormonal stimulation (Fig. 4). We also tried
to analyse possible hormone-induced changes of the minor-
ity pool of Flag-hIPR recovered in membrane domain area
(fractions 4–6), but this task was difficult to perform
because of very low intensity of Flag immunoblot signal
in low-density fractions (Fig. 5A). Detection of Flag-hIPR
in DIMs/caveolae was achieved by introduction of ECL
with higher sensitivity (Super Signal West Pico and Dura,
Pierce) and longer exposure times (Fig. 5B). Comparison of
samples from control and iloprost-treated cells by densito-
metric scanning did not indicate any difference (Fig. 5C).from Flag-hIPR-Gsa expressing cells. Cells were grown and fractionated on
unoblot signals of membrane domain (4–6) and soluble (9–11) fractions
the same immunoblot. (B) Distribution of Gia protein in membrane domain
for determination of Gia proteins. Typical gradient profiles were collected
Table 1
GPCRs and transmembrane PM markers in DIMs
(A) GPCR Percent of total amount
Flag-hIPR (Flag immunoblot, 0.5 min)a 3%
Flag-hIPR (Flag immunoblot, 0.5 min)b ND











(a subunit, polyclonal Ab)
tCD58c ND
CD44c 11%
The immunoblot signals in low-density fractions 4–6 isolated by detergent-
extraction and flotation in density gradient was determined by densitometric
scanning and compared with total signal detected in all fractions. ND=not
detectable in fractions 3–6; immunoblot signal located exclusively in high-
density fractions 8–12.
a Analysed on a simple 40%, 35% and 5% (w/v) sucrose density
gradient (see Section 2) according to Galbiati et al. [30]; average of three
fractionation procedures.
b Analysed on 40%, 35%, 30%, 25%, 20%, 15%, 10% and 5% (w/v)
sucrose density gradient (see Section 2) according to Pesanova et al. [20];
average of three fractionation procedures.
c Averaged in two gradients type a and in two gradients type b.
Table 2
Ga subunits in DIMs










The immublot signal in low-density fractions 4–6 was determined by
densitometric scanning and compared with total signal recovered in all
fractions.
a Analysed on a simple 40%, 35% and 5% (w/v) sucrose density gradient
prepared according to Galbiati et al. [30]; average of three fractionation
procedures.
b Analysed on 40%, 35%, 30%, 25%, 20%, 15%, 10% and 5% (w/v)
sucrose density gradient according to Pesanova et al. [20]; average of three
fractionation procedures.
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detergent-solubilised fractions 8–12.
Agonist-induced change in subcellular localisation of
Gsa and IP-prostanoid receptors was further studied in
HEK293 cells expressing the FhIPR-Gsa fusion protein.
In these cells, both endogenous Gsa and receptor fusion
protein could be characterised by the same Gsa-specific
antiserum on the same immunoblot (Fig. 6). In accordance
with previous data obtained in FhIPR-expressing cells,
iloprost stimulation (1 AM, 2 h) resulted in preferential
decrease of endogenous Gsa in DIMs when compared with
detergent-solubilised fractions (Fig. 7A). The decrease of
endogenous Gsa was receptor-specific because the level of
Gia protein did not change (Fig. 7B). Thus, similarly to data
obtained in FhIPR-expressing cells, domain-bound pool of
Gsa responded more readily to hormonal stimulation than
that recovered among detergent-solubilised cell constituents.
When using Flag-oriented antibodies, the dominant por-
tion of FhIPR-Gsa was detected as a diffuse signal in non-
floating, high-density area. Similarly as in FhIPR-express-
ing cells (Figs. 4 and 5), a weak signal, just at the minimum
threshold level of ECL detection, was observed in DIMs.
Neither of the two pools of receptor protein was altered by
iloprost stimulation (data not shown). The ratio between
DIMs-bound and detergent-solubilised pool of FhIPR-Gsa
was extremely low, because the substantial majority of the
receptor (>95% of total gradient amount) was localised in
high-density fractions 8–12 (Table 1A). This pattern ofreceptor distribution was similar, if not identical, with many
transmembrane PM markers (Table 1B) known to be fully
solubilised by nonionic detergents such as 1% TX-100.
These transmembrane PM markers included glycosylated
(g) and non-glycosylated (ng) forms of M6 (CD147), MHCI
(major histocompatibility complex, class I), CD29 (integrin
h1 subunit), Tapa 1, the a subunit of Na,K-ATPase, trans-
membrane form of CD58 and CD44 (lymphocyte homing
receptor-fagocytic glycoprotein).
Sensitivity of Gsa proteins to detergent extraction dif-
fered substantially from that of hIP prostanoid receptors and
transmembrane protein molecules (Table 2). As much as
40–50% of total signal of Gsa subunits was present in
DIMs and the remaining 60–50% of this protein was
recovered among soluble, non-floating constituents. It may
be therefore concluded that only a small fraction (1–3%) of
the total cellular amount of receptor molecules is associated
with the much larger fraction (40–50%) of the cognate Ga
protein subunits in DIMs.
The data obtained by detection of FhIPR and FhIPR-Gsa
using Flag-oriented antibodies were supported by simulta-
neous detection of both receptor fusion protein and endog-
enous Gsa on the same immunoblot by CS antiserum. The
dominant portion of receptor molecules was localised in
high-density, non-floating, detergent-solubilised fractions
8–12 and only about 1% of the receptors was detected in
DIMs. The ratio between receptor fusion protein and Gsa in
DIMs was 1:50 (Fig. 6).
3.2. Long-term agonist stimulation is associated with
unchanged level of hIP prostanoid receptor and dramatic
reduction of Gsa protein in detergent-free (alkaline-treated)
preparations of membrane domains
General validity of the results derived from studies of
DIMs, namely (i) preferential decrease of Gsa in DIMs
when compared with detergent-solubilised fractions and (ii)
unchanged distribution of receptor protein after agonist
Fig. 8. Depletion of endogenous Gsa and unchanged level of receptor fusion protein in alkaline-treated (detergent-free) membrane domains. FhIPR- (A) or
FhIPR-Gsa- (B) expressing HEK293 cells were cultivated and treated with 1 M Na2C03 as described in Section 2. Alkaline-treated domains were prepared
from the same amount (9 80-cm2 flasks) of control and iloprost- (1 AM, 2 h) stimulated cells. Samples of TCA-precipitated fractions were resolved by SDS-
PAGE, immunoblotted with Gsa-oriented antibodies and immunological signal corresponding to Gsa and FhIPR-Gsa detected by ECL. Typical immunoblots
of a single fractionation procedure (F iloprost) were shown.
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preparations of these structures. For preparation of mem-
brane domains by alkaline treatment and sonication, we
used a protocol originally described by Song et al. [23,24].
Comparison of representative immunoblots of density
gradient profiles obtained from FhIPR-expressing cells
(F iloprost) indicated that iloprost stimulation caused a
substantial reduction of endogenous Gsa levels in mem-
brane domains (fraction 5) prepared by alkaline treatment
(Fig. 8A). The level of Gia proteins was unchanged (data
not shown). The specificity of hormone response in FhIPR-
expressing cells was thus manifested in DIMs as well as in
detergent-free preparation of membrane domains. FhIPR-
Gsa fusion protein was detected by immunoblotting with
Gsa-specific antiserum as a polypeptide with relative mo-
bility of about 90 kDa (Fig. 8B). The maximum level of
FhIPR-Gsa was detected in fraction 8 corresponding to 35%
(w/v) sucrose. This signal was clearly unchanged when
compared with dramatic reduction of endogenous Gsa
detected in 45–52-kDa range of Mr. The maximum intensity
of both the long and short variants of Gsa was localised in
fraction 5 corresponding to 20% sucrose. (Fig. 8B).
The lack of agonist-induced effect on IP prostanoid
receptor content in alkaline-treated domains was verified
by detection with Flag-oriented antiserum M5 (Sigma,
IB13091). The immunoblot signal of FhIPR (Mrc 90
kDa) was detected in a narrow, distinct area of polyacryl-
amide gel and its maximum was localised in fraction 8 (35%
sucrose). Samples from control and iloprost-stimulated cellsFig. 9. Detection of FhIPR in alkaline-treated domains by Flag-oriented
antibody. The same amounts of HEK293 cells expressing FhIPR receptor
treated or untreated with iloprost (1 AM, 2 h) were fractionated according to
‘‘alkaline treatment’’ procedure and the distribution of receptor protein was
identified by Flag-oriented antiserum M5 from Sigma (IB13091). TCA-
precipitated gradient fractions obtained from control and iloprost-stimulated
cells were analysed. Typical immunoblots of a single fractionation
procedure (F iloprost) were shown.contained the same amount of FhIPR protein (Fig. 9). This
clear-cut result was rather surprising in view of our previous
difficulties when analysing detergent-extracted preparations,
which exhibited diffuse immunoblot signals of both FhIPR-
and FhIPR-Gsa spreading over a wide range of Mr when
resolved in polyacrylamide gels (compare with Figs. 4 and
5). It may be assumed that extraction in a highly alkaline
solution of 0.5 M Na2CO3 at pH 11 might have revealed
(unmasked) more clearly the Flag-antigenic determinants in
receptor fusion protein. In DIMs, these determinants were
probably buried by excess of the detergent. Alternatively,
the hydrolytic cleavage in alkaline solution could cause
deglycosylation of the C-terminus of GPCRs. In any case,
the analysis of alkaline-treated preparations of membrane
domains brought a strong support for the conclusions
primarily formulated by studies of DIMs, i.e., that pro-
longed stimulation of IP prostanoid receptor induces pref-
erential depletion of Gsa protein in membrane domains,
whereas the level of receptor protein is unchanged.4. Discussion
Exposure of cells to agonists of receptors linked to G
proteins results in down-regulation, i.e., decrease of the total
cellular amount of their cognate G proteins [48]. Agonist-
induced reductions in G protein levels, which have been
observed for different members of each of the Gs, Gi and Gq
families of G proteins, depend on the level of receptor
expression and are generally restricted to the G protein with
which a given receptor interacts [48–53]. This phenomenon
may be potentially important in drug therapy/pathophysiol-
ogy, because it can provide a mechanism for the develop-
ment of sustained heterologous desensitisation—refractility.
The mechanism(s) responsible for down-regulation of
trimeric G proteins vary with cell type, include second
messenger-dependent and -independent mechanisms, and
manifest slowly within the time scale of hours. As the
transcriptional or translational control does not contribute
significantly to this process, enhanced proteolytic degrada-
tion occurring inside the cell seems to be of the primarily
importance [50,51,54]. Here we might encounter the prob-
lem of G protein internalisation.
In the Gq/G11-mediated signalling cascade initiated by
thyrotropin-releasing hormone receptor, the internalisation
of GPCRs (TRH-R) is a rapid process proceeding within
minutes via clathrin-dependent pathway [14–17]. On the
other hand, internalisation of Gqa/G11a proteins is not
detectable before 60 min of incubation with the hormone
and is fully manisfested only after 2–4 h of agonist
exposure [2]. Subsequently, after prolonged hormonal treat-
ment (8–16 h), the down-regulation of Gqa/G11a takes
place. Thus, the G protein internalisation precedes its
down-regulation. The difference in the time scale of
TRH-R and G protein internalisation was characterised first
by subcellular fraction studies [12] and later confirmed by
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protein (VSV-TRH-R-GFP) and immuno(fluorescence) de-
tection of Gqa/G11a [3,55]. Accordingly, a recent work of
Sorensen et al. [18] has demonstrated that agonist-induced
endocytosis of muscarinic receptors and Gq/G11 proceeds
by distinct mechanisms. Although muscarinic receptor
translocation was prevented by either depletion of phos-
phoinositides or by disruption of clathrin assembly, the
endocytosis of Gq/G11 was unaffected. It has been also
shown that the hormone-dependent internalisation of TRH-
R proceeds without functional coupling between receptor
and G protein [16] or in cells lacking Gq/G11 [17]. Thus,
TRH-R and Gq/G11 follow different pathways in the course
of internalisation.
As the internalisation of TRH-R and other GPCRs [14–
17,56,57] proceeds via clathrin-dependent pathway, the
question arises which pathway is used in the course of
internalisation of trimeric G proteins. The mechanism of Gq/
G11 internalisation is unknown, but it is not affected by the
established inhibitors of clathrin-mediated pathway [2]. The
slow speed of G protein internalisation and down-regulation
(hours), together with discussions about relative participa-
tion of caveolar versus clathrin-mediated pathways in the
case of h-adrenergic receptor internalisation [58–60], drew
our attention to ‘‘caveolar transport’’, which has been
described as a relatively slow process [19].
Caveolae are isolated as detergent-insensitive/resistant
membrane domains (DIMs/DRMs) from cells expressing
caveolin by flotation on sucrose density gradients [61–64].
Over 99% of total membrane protein is solubilised in
nonionic detergents such as TX-100 (1%, 30–60 min on
ice) and remains in non-floating, high-density area of
density gradient (>40% sucrose). Small fraction of mem-
brane protein is insensitive (resistant) to detergent extrac-
tion. These ’’mixed detergent– lipid–protein micelles’’
exhibit low density and migrate (float) to the low-density
region containing 15–20% sucrose. In this way, DIMs/
caveolae are separated from bulk of PM proteins, which
are fully solubilised by the detergent.
The short-term effects of hormones or neurotransmitters
on composition of membrane sub-domains/caveolae have
been extensively studied in the past few years [29,31,65–
72], but no consistent conclusion might be drawn from these
heterogeneous observations. Heterotrimeric G proteins as
well as GPCRs have been described as moving into or out
from such domains as direct consequence of hormonal
stimulation. It is unclear whether these movements are
intrinsically related to activation or inhibition of G protein
functional activity. In spite of intensive experimental efforts
devoted to this problem, we were unable to detect any
subcellular redistribution of Gqa/G11a or Gsa proteins
within short time periods (minutes) of agonist stimulation.
Regardless whether using immunoprecipitation or density
gradient purification, the levels of trimeric G proteins in
DIMs/caveolae were unchanged up to 30 min of agonist
exposure. The only significant and reproducible data wereobtained after long-term (>30–60 min) stimulation. This
finding is in line with our previous measurements of G
protein internalisation, which was not detectable before 60
min of agonist exposure. In cells expressing high levels of
TRH-R and G11a, the DIMs/caveolar level of both endog-
enous Gqa and exogenously expressed G11a was dramati-
cally decreased by prolonged stimulation with TRH [20].
The observed concomitant increase of the G proteins in
high-density area of the gradient was due to solubilisation of
Gqa/G11a, which also proceeds in these cells [12].
The aim of our present study was to analyse the Gsa-
mediated pathway in cells where both Gsa and the
corresponding receptor may be investigated simultaneously.
The epitope-tagged version of IP prostanoid receptor
(FhIPR) as well as fusion protein FhIPR-Gsa were prepared
for this aim. The fusion construct allowed detection of both
receptor and Gsa by the same antibody. Analysis of Gsa-
mediated pathway was motivated by recent demonstration
of the fast agonist (isoproterenol)-induced internalisation of
Gsa-GFP [13] as well as by our previous studies indicating
solubilisation and PM–light vesicles shift of Gsa initiated
by isoproterenol stimulation of S49 lymphoma cells [10,73].
As observed earlier with Gqa/G11a, the first detectable
change (decrease) of Gsa occurred after 30–60 min of
agonist exposure and it further deepened in the course of
subsequent 2–4 h of stimulation. Under these conditions,
significant down-regulation also occurred. Prolonged stimu-
lation of IP prostanoid receptor (1–2 h) resulted in preferen-
tial reduction of domain-bound pool of the cognate G proteins
GsaL and GsaS. In contrast, the receptor level was un-
changed. Thus, the present analysis of detergent-insensitive
(DIMs) as well as alkaline-treated (detergent-free) prepara-
tions of membrane domains revealed a major difference in the
behaviour of IP prostanoid receptor and Gsa protein. In this
context it is worth to note our previous data indicating the
difference in behaviour of TRH-Rs and their cognate Gqa/
G11a proteins in the course of internalisation [2].
This was not the only difference between the receptor
and its cognate G protein that was noticed in our present
work. A striking difference showed up in the susceptibility
of Gsa and IP prostanoid receptor towards detergent extrac-
tion. While over 95% of immuno-detectable receptor was
solubilised by Triton X-100, Gsa protein was distributed
almost equally between DIMs and detergent-solubilised
phase. Our quantitative estimation of the G protein/GPCR
stoichiometry in DIMs/caveolae under control conditions
indicated clearly that there was a large excess of G protein
molecules over corresponding receptors in these structures.
Expressed as percent of total cellular amount, less than 5%
of FhIPR or FhIPR-Gs was present in DIMs together with
30–40% of G proteins. When assayed simultaneously on
the same immunoblot by the same antiserum, the G-protein/
GPCR ratio was 1:50 in DIMs (Fig. 6) and 1:20 in domains
isolated by alkaline treatment (Fig. 8B). The dominant pool
of IP prostanoid receptors, like most other transmembrane
proteins, remained in detergent-solubilised phase (40%
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dered phase of PM, which is fully solubilised by nonionic
detergents [74] such as Triton X-100 (TX-100 has been
most frequently used in DIMs/DRMs isolation and therefore
represents a sort of standard reagent in recognition of what
is domain-bound and what is not), exhibits preferential
affinity for the receptors. In contrast, trimeric G proteins,
depending on functional state, partition in both ordered
(domains) and disordered (detergent-solubilised) phase.
As mentioned above, recently a lot of heterogeneous data
have been published concerning the distribution of GPCRs
and G proteins in DIMs/caveolae [29,31,65,68–70]. The
functional significance of association of these signalling
molecules with DIMs/caveolae is still not quite clear. The
original idea that DIMs/caveolae serve as compartment(s)
for recruitment of components of signalling pathways to
increase efficiency and/or speed of functional coupling
between receptor(s) and effector(s) [63,64] is contradicted
by an alternative theory accenting the view that caveolae
attract the components of signalling cascades to desensitise
or terminate the receptor signal. Our current identification
of two pools of signalling molecules separated by detergent
extraction and flotation of remaining membrane fragments
on density gradient allows to bring a more coherent view to
recent literature describing hormone-induced redistribution
of GPCRs and G proteins in or out from DIMs/caveolae.
The simple interpretation that GPCRs and G proteins
redistribute within dynamically arising and disappearing
DIMs/DRMs (caveolae represent just one subtype) does
not consider the bulk of PM, which is fully solubilised by
detergents and, a priori, must contain a significant portion of
these signalling molecules. This is what we have experi-
mentally shown in the present study.
In our opinion, the DIMs-bound pool of GPCRs as well
as other transmembrane PM markers represents a very small
fraction of their total cellular amount. Therefore, hormone
stimulation has to be realised either by a minute fraction of
total cellular GPCRs (remember spare receptor concept
formulated in pharmacological studies of hormone action)
or by movements of receptors in and out of DIMs. As direct
G protein activation is too fast for this sort of ‘‘long-range‘‘
movements, we would regard the first possibility more
plausible. In this case, the major pool of receptors (present
in soluble phase after detergent-extraction) might represent
spare receptors not directly participating in hormone action.Acknowledgements
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